PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Lorecivivint, page-2

  1. 92 Posts.
    lightbulb Created with Sketch. 10
    Hmm, I don't remember hearing about this one before. Thx for posting this!

    That was from 2020 and they were already about to commence Phase 3.
    I'm hoping their drug's efficacy is lower than ours. At least we have some other irons in the fire outside of OA I guess.
    Last edited by thegajman: 12/11/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.